Navigation Links
Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
Date:10/23/2007

statements as a result of these risks and uncertainties, which include, without limitation, the risk that Sunesis' drug discovery and development activities could be halted significantly or delayed for various reasons, the risk that Sunesis' clinical trials for SNS-595 may not demonstrate safety or efficacy or lead to regulatory approval, the risk that preliminary data and trends may not be predictive of future data or results, the risk that Sunesis' preclinical studies and clinical trials may not satisfy the requirements of the FDA or other regulatory agencies, risks related to the conduct of Sunesis' clinical trials and manufacturing of SNS-595 and risks related to Sunesis' need for additional funding. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' annual report on Form 10-K for the year ended December 31, 2006 and other filings with the Securities and Exchange Commission. Sunesis expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.


'/>"/>
SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
2. Sunesis Pharmaceuticals Reports Positive Data From Studies of Two Anti-Cancer Agents, SNS-595 and SNS-032, at the 12th Congress of the European Hematology Association
3. Sunesis Pharmaceuticals to Present Data at the 12th Congress of the European Hematology Association
4. Sunesis Presents Data Supporting SNS-032s Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
5. Sunesis Pharmaceuticals to Present Data at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals Presents SNS-314 Aurora Kinase Inhibitor Data Showing Broad Anti-Tumor Activity, Dosing Flexibility
7. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... 2015 Semler Scientific, Inc. (Nasdaq: SMLR ... manufactures and markets products that assist healthcare providers in ... results for the first quarter ended March 31, 2015. ... Semler reported continued progress with year over year growth ... of 14%," said Doug Murphy-Chutorian , M.D., chief ...
(Date:5/1/2015)... 2015  Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: ... following the results of the Phase 3 Rocket 1 ... trial failing to meet its end points, compelling data ... from future studies. An analyst report on ... financial review, analyst summary, valuation, and recommendation can be ...
(Date:4/30/2015)... , April 30, 2015  Accuray Incorporated ... has signed an agreement with MIM Software Inc. ... TomoTherapy ® and CyberKnife ® product portfolios. ... and MIM technology. This is Accuray,s second collaboration ... development of the first iPad-based treatment plan review ...
Breaking Medicine Technology:Semler Reports First Quarter 2015 Financial Results 2Semler Reports First Quarter 2015 Financial Results 3Semler Reports First Quarter 2015 Financial Results 4Semler Reports First Quarter 2015 Financial Results 5All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 2Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software 3
... Minimally Invasive Devices, Inc. , (MID) has been ... laparoscopic visualization system.  This certification is mandatory for sale ... The FloShield system provides for an uninterrupted ... the insufflator to defog and deflect debris from the ...
... Chimerix, Inc., a biotechnology company developing orally-available antiviral ... the Board and Chief Scientific Officer, will participate on ... Therapeutics Conference on July 22nd, 2011, 10:30 am ET. ... Club in Washington, D.C. on July 20-22, 2011, and ...
Cached Medicine Technology:Minimally Invasive Devices, Inc. Awarded CE Mark for FloShield™ 2Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 2Chimerix to Present at Infocast's 9th Annual Biodefense Vaccines & Therapeutics Conference 3
(Date:5/1/2015)... TROY Healthcare Solutions is proud to ... Group (RUG) Conference in Atlanta, GA from May 6 ... Conference provides a forum for client-to-client presentations, continuing education ... of electronic medical record operations, as well as showcasing ... In addition to sponsoring the event, TROY Healthcare Solutions ...
(Date:5/1/2015)... Hope For The Warriors® thanks All American ... Warriors® and military families. All American Ford presented two ... Warriors®, a national nonprofit dedicated to restoring a sense ... for our service members and our military families. , ... and matched small autograph fee from fans and presented ...
(Date:5/1/2015)... The fields of genetics and genomics, the ... genes with one another and the environment, is rapidly ... LabRoots, the premier producer of interactive virtual events for ... its annual conference spotlighting the recent advances in Genetics ... Genomics 2015 , a two-day event presented entirely online ...
(Date:5/1/2015)... Today the United Nations Foundation’s Girl Up campaign announced that ... the rights of adolescent girls in India. This announcement ... Up began almost five years ago – kicks off a ... the Rajasthan region of India. , “For the past ... girls in Guatemala, Ethiopia, Liberia, and Malawi. As we ...
(Date:5/1/2015)... 01, 2015 Digital technology and Wi-Fi-enabled ... women between prenatal appointments, a preliminary study ... small sample of low-risk pregnant women, will be presented ... University Medical Faculty Associates at the 2015 American Congress ... Meeting, May 2-6. The digital technology used was developed ...
Breaking Medicine News(10 mins):Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 2Health News:TROY Healthcare to Exhibit at the Cerner Southeast Regional User Group Conference 3Health News:All American Ford Presents Donation to Nonprofit Hope For The Warriors 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 2Health News:United Nations Foundation’s Girl Up Campaign Announces New Funding Initiative to Support Adolescent Girls in India 3Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 2Health News:Mobile Technology May Be Effective in Monitoring Pregnant Women Between Office Visits, Study Shows 3
... one of the most "wired" hospitals in the U.S. ... ... 2008 -- Artromick provides accurate and efficient medication management solutions ... In today's demanding world of health care, hospitals, like Camden-Clark ...
... with tools to lead a healthy ... ... the National Council of La Raza (NCLR) to unveil a small,tool aimed at ... pocket-sized health book, Buena Salud, Buena Vida --,Su Guia de Recursos de Salud, ...
... clinicians, including intelligent innovations that redefine the way women in healthcare ... enhancements, Medelita sets a new standard for quality, comfort, performance and ... alone wearing scrubs and lab coats to work. , ... ...
... Emergency department ,teachable moments, remembered well by parents, youngsters, ... Pediatric trauma centers and emergency departments are good places ... reduce the threat of injury, according to researchers at ... , "We know that children who are admitted to ...
... for antibiotics under the fluoroquinolones drug family that will now require a ... instituted the mandate due to the greater risk of tendonitis and tendon ... ... 2008 -- LegalView, the number one resource for everything legal on the ...
... to the,Senate, forty-five leading human rights and global ... legislation that would,reauthorize the President,s Plan for AIDS ... a five-year, $50 billion HIV/AIDS relief package, the,organizations ... policies based,on evidence gathered and lessons learned after ...
Cached Medicine News:Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 2Health News:Developer of Mobile Hospital Computing Equipment and Medical Carts Helps Hospital Upgrade to Wireless 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 2Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 3Health News:Lilly Partners With the National Council of La Raza to Fight Chronic Disease 4Health News:Medelita Introduces A Breakthrough In Healthcare Uniforms For Women 2Health News:Medelita Introduces A Breakthrough In Healthcare Uniforms For Women 3Health News:Trauma Center Counseling Reduces Kids' Repeat Injuries 2Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 2Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 3Health News:LegalView Reveals Details of the FDA Mandated Black Box Warning For Fluoroquinolone Antibiotics Such as Cipro and Levaquin 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 2Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 3Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 5
Neuropack Sigma MEB-5500 series evoked potential measuring system is a compact, portable, all-in-one unit....
Neuropack MEB-2200 evoked potential/EMG measuring system is user friendly Windows NT, Pentium III PC-based EP/EMG measuring system....
... line of Myoquick systemplus Multi-channels Evoked Potential testing ... in the neurophysiology field and shows the extremely ... unit adopt the 32 channels headbox BQ 132S ... ISA 100x EP family headboxes: ISA 1002 EP ...
... 6 popular colors to match any ... to accommodate wheel chair patients and ... and quiet elctro-mechanical up/down movement. Easy ... programmable memory Patient safety impact guard ...
Medicine Products: